Back to Journals » OncoTargets and Therapy » Volume 12

Siglecs, Novel Immunotherapy Targets, Potentially Enhance The Effectiveness of Existing Immune Checkpoint Inhibitors in Glioma Immunotherapy

Total article views   HTML views PDF downloads Totals
6,387 Dovepress* 5,092+ 1,065 6,157
PubMed Central* 1,295 536 1,831
Totals 6,387 1,601 7,988
*Since 27 November 2019
Total mentioned Facebook Delicious Reddit Twitter Others
12 0 0 0 6 6

View citations on PubMed and Google Scholar